Birgitta Rosengren - Concepedia

Author

Birgitta Rosengren

AstraZeneca (Sweden)

Also Known As

B ROSENGREN, B Rosengren, B. ROSENGREN, B. Rosengren, Birgitta E. Rosengren, Birgitta Rosengren

Publications

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (Sweden)University of Gothenburg Sahlgrenska University Hospital Wallenberg Wood Science Center Kungälvs Sjukhus

About

Birgitta Rosengren is an author at AstraZeneca (Sweden) specializing in medicine, vascular biology, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.4K
2	Engineering	1	1	56
3	Health Sciences	1	1	283
4	Natural Sciences	1	1	162
5	Anatomy	1	1	13

Birgitta Rosengren

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Lipoprotein Oxidation and Measurement of Thiobarbituric Acid Reacting Substances Formation in a Single Microtiter Plate: Its Use for Evaluation of Antioxidants Boel Wallin, Birgitta Rosengren, Howard G. Shertzer, Analytical Biochemistry Food ChemistryBiochemistrySingle Microtiter PlateMedicineLipid Peroxidation	1993	335
Human brain gangliosides: developmental changes from early fetal stage to advanced age Lars Svennerholm, Kerstin Boström, Pam Fredman, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism Advanced AgeBasal GangliaBrain DevelopmentDevelopmental Cognitive NeuroscienceCerebral Organoid	1989	283
Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Eva Hurt‐Camejo, Germán Camejo, Birgitta Rosengren, Arteriosclerosis and Thrombosis A Journal of Vascular Biology Vascular DiseaseLipid PeroxidationCellular PhysiologyOxidative StressInflammation	1992	182
Role of ADAMTS-1 in Atherosclerosis Ann‐Cathrine Jönsson‐Rylander, Tina Nilsson, Regina Fritsche‐Danielson, Arteriosclerosis Thrombosis and Vascular Biology	2004	173
Localization of Nonpancreatic Secretory Phospholipase A <sub>2</sub> in Normal and Atherosclerotic Arteries Eva Hurt‐Camejo, Sonja Andersen, Rune Standal, Arteriosclerosis Thrombosis and Vascular Biology	1997	171
Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages. Eva Hurt‐Camejo, Germán Camejo, Birgitta Rosengren, Journal of Lipid Research Lipid AnalysisLdl SubpopulationsImmunologyBiomedical EngineeringLipid Movement	1990	162
Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells Germán Camejo, Gunnar Fager, Birgitta Rosengren, Journal of Biological Chemistry MechanobiologyLow Density LipoproteinGlycosylationBiochemistryLow Density Lipoproteins	1993	142
Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: Possible contribution of phospholipase A2 to this atherogenic profile Eva Hurt‐Camejo, Sílvia Paredes, L. Masana, Arthritis & Rheumatism	2001	138
Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages Germán Camejo, Carina Halberg, Angela Manschik-Lundin, Journal of Lipid Research	1998	134
An oral antisense oligonucleotide for PCSK9 inhibition Peter Gennemark, Katrin Walter, Niclas Clemmensen, Science Translational Medicine	2021	117

Page 1